Cargando…
GM-CSF targeting in COVID-19: an approach based on fragile foundations
Trials of anti-GM-CSF therapies in COVID-19 show divergent results; this may be explained by underlying biology and the fragility of the study findings. Further investigation of the pathophysiology of COVID-19 is required to better target therapies. http://bit.ly/3O1AuIo
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686318/ https://www.ncbi.nlm.nih.gov/pubmed/36396141 http://dx.doi.org/10.1183/13993003.02091-2022 |
| _version_ | 1784835718595477504 |
|---|---|
| author | Kohler, Katharina Conway Morris, Andrew |
| author_facet | Kohler, Katharina Conway Morris, Andrew |
| author_sort | Kohler, Katharina |
| collection | PubMed |
| description | Trials of anti-GM-CSF therapies in COVID-19 show divergent results; this may be explained by underlying biology and the fragility of the study findings. Further investigation of the pathophysiology of COVID-19 is required to better target therapies. http://bit.ly/3O1AuIo |
| format | Online Article Text |
| id | pubmed-9686318 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96863182022-11-25 GM-CSF targeting in COVID-19: an approach based on fragile foundations Kohler, Katharina Conway Morris, Andrew Eur Respir J Editorials Trials of anti-GM-CSF therapies in COVID-19 show divergent results; this may be explained by underlying biology and the fragility of the study findings. Further investigation of the pathophysiology of COVID-19 is required to better target therapies. http://bit.ly/3O1AuIo European Respiratory Society 2023-02-02 /pmc/articles/PMC9686318/ /pubmed/36396141 http://dx.doi.org/10.1183/13993003.02091-2022 Text en Copyright ©The authors 2023. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
| spellingShingle | Editorials Kohler, Katharina Conway Morris, Andrew GM-CSF targeting in COVID-19: an approach based on fragile foundations |
| title | GM-CSF targeting in COVID-19: an approach based on fragile foundations |
| title_full | GM-CSF targeting in COVID-19: an approach based on fragile foundations |
| title_fullStr | GM-CSF targeting in COVID-19: an approach based on fragile foundations |
| title_full_unstemmed | GM-CSF targeting in COVID-19: an approach based on fragile foundations |
| title_short | GM-CSF targeting in COVID-19: an approach based on fragile foundations |
| title_sort | gm-csf targeting in covid-19: an approach based on fragile foundations |
| topic | Editorials |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686318/ https://www.ncbi.nlm.nih.gov/pubmed/36396141 http://dx.doi.org/10.1183/13993003.02091-2022 |
| work_keys_str_mv | AT kohlerkatharina gmcsftargetingincovid19anapproachbasedonfragilefoundations AT conwaymorrisandrew gmcsftargetingincovid19anapproachbasedonfragilefoundations |